📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Vismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuation. (2019)

First Author: Ighilahriz M

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/jdv.15741

PubMed Identifier: 31187903

Publication URI: http://europepmc.org/abstract/MED/31187903

Type: Journal Article/Review

Volume: 33

Parent Publication: Journal of the European Academy of Dermatology and Venereology : JEADV

Issue: 11

ISSN: 0926-9959